ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.65
-0.26%
US Tech 100
19,215.20
0.25%
S&P 500
5,431.60
-0.04%
US Dollar vs CAD
1.37394
-0.09%
Bitcoin
66,161.59
-0.72%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Co Diagnostics Inc (CODX)

  7. Co Diagnostics Inc (CODX) News

CODX

Co Diagnostics (CODX)

Co Diagnostics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CODX
DateTimeSourceHeadlineSymbolCompany
06/14/20248:30AMPR Newswire (US)Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro PlatformNASDAQ:CODXCo Diagnostics Inc
06/14/20246:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CODXCo Diagnostics Inc
05/28/20243:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CODXCo Diagnostics Inc
05/28/20243:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CODXCo Diagnostics Inc
05/09/20243:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CODXCo Diagnostics Inc
05/09/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CODXCo Diagnostics Inc
05/09/20243:01PMPR Newswire (US)Co-Diagnostics, Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:CODXCo Diagnostics Inc
04/25/20248:30AMPR Newswire (US)Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and WebcastNASDAQ:CODXCo Diagnostics Inc
04/24/20248:30AMPR Newswire (US)Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in TaiwanNASDAQ:CODXCo Diagnostics Inc
04/12/20248:30AMPR Newswire (US)Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting EventNASDAQ:CODXCo Diagnostics Inc
04/04/20248:30AMPR Newswire (US)Co-Diagnostics, Inc. Appoints New President and Other C-Level PositionsNASDAQ:CODXCo Diagnostics Inc
03/21/20248:30AMPR Newswire (US)Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote AddressNASDAQ:CODXCo Diagnostics Inc
03/18/20248:30AMPR Newswire (US)Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, EnglandNASDAQ:CODXCo Diagnostics Inc
03/14/20243:01PMPR Newswire (US)Co-Diagnostics, Inc. Reports Full Year 2023 Financial ResultsNASDAQ:CODXCo Diagnostics Inc
03/07/20248:30AMPR Newswire (US)Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR TestNASDAQ:CODXCo Diagnostics Inc
02/29/20248:30AMPR Newswire (US)Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and WebcastNASDAQ:CODXCo Diagnostics Inc
02/01/20248:30AMPR Newswire (US)Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024NASDAQ:CODXCo Diagnostics Inc
01/03/20248:30AMPR Newswire (US)Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12NASDAQ:CODXCo Diagnostics Inc
12/27/20238:30AMPR Newswire (US)Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR ProNASDAQ:CODXCo Diagnostics Inc
11/29/20238:30AMPR Newswire (US)Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023NASDAQ:CODXCo Diagnostics Inc
11/27/20233:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CODXCo Diagnostics Inc
11/27/20233:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CODXCo Diagnostics Inc
11/27/20233:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CODXCo Diagnostics Inc
11/09/20233:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CODXCo Diagnostics Inc
11/09/20233:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CODXCo Diagnostics Inc
11/09/20233:01PMPR Newswire (US)Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial ResultsNASDAQ:CODXCo Diagnostics Inc
11/02/20238:30AMPR Newswire (US)Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in DevelopmentNASDAQ:CODXCo Diagnostics Inc
10/31/20238:30AMPR Newswire (US)Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023NASDAQ:CODXCo Diagnostics Inc
10/26/20238:30AMPR Newswire (US)Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and WebcastNASDAQ:CODXCo Diagnostics Inc
10/23/20238:30AMPR Newswire (US)Co-Diagnostics, Inc. to Host Booth at CASMET Symposium October 23-25NASDAQ:CODXCo Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:CODX

Your Recent History

USOTC
CNNA
Cann American (CE)
USOTC
HHSE
Hannover House (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
RNVA
Rennova Health (PK)
USOTC
RONN
Ronn Motor (PK)
NASDAQ
COOP
Mr Cooper
USOTC
ELTP
Elite Pharmaceuticals (QB)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
CIVX
CTR Investments and Cons... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
FNMA
Fannie Mae (QB)
USOTC
SMCE
SMC Entertainment (PK)
USOTC
SPZI
Spooz (PK)
NASDAQ
DJT
Trump Media and Technology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved